Skip to main content
Premium Trial:

Request an Annual Quote

Invicro, Yale Partner to Advance Biomarker Detection Tech

NEW YORK — Invicro said on Monday that it has partnered with the Yale University School of Medicine to refine an imaging-based tissue biomarker detection technology for clinical pathology applications.

Under the deal, Invicro — a Boston-based subsidiary of Konica Minolta — will work with Yale pathologist David Rimm to advance Quanticell, a technology that uses photostable and bright phosphor-integrated dots for quantitative, amplification-free detection of proteins at cellular and subcellular levels.

According to Invicro, Rimm and his research team will evaluate different assay conditions to assess Quanticell's performance for quantifying HER-2 expression across a wider dynamic range than chromogenic-based immunohistochemistry.

Additional terms of the partnership were not disclosed.

"With his unmatched knowledge and experience in anatomical pathology, product commercialization, and late-stage clinical trials … Rimm is a leading pioneer in the quantitative pathology space," Ken Bloom, chief medical officer for advanced pathology solutions at Invicro, said in a statement. "I am highly confident that his efforts will support the advancement of Quanticell for specific drug development initiatives."

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.